INTRODUCTION
============

Desflurane has been reported to prolong the QTc interval in healthy adults[@B1]-[@B3] and children[@B4] during anesthesia induction. In guinea pig ventricular myocardium *in vitro*,[@B5] desflurane apparently prolonged the action potential (AP) duration by inhibiting the slowly activating delayed outward K^+^ current.

Cardiac AP duration is determined by balance between the inward and outward membrane currents.[@B6],[@B7] In most species, the transient outward K^+^ current (I~to~) is responsible for the initial phase of repolarization, and the L-type Ca^2+^ current (I~Ca,L~) is the main inward current during the plateau phase. Near the end of the ventricular AP plateau, delayed outward K^+^ current (I~K~) activation initiates repolarization, and the inward rectifier K^+^ current (I~KI~) plays an important role in generating the resting membrane potential and modulating the final repolarization phase of ventricular AP.[@B7]

The contributions of these currents vary between species and are responsible for characteristic differences in AP shape. For example, rat ventricular myocytes possess a prominent I~to~, the major outward current of the repolarization phase but little I~K~, and have a short AP duration. In contrast, guinea pig ventricular cells lack I~to~, but have a slowly activating I~K~, resulting in a long-lasting AP.[@B8] While the current density of I~to~ in human ventricular myocytes (8.2±0.7 pA/pF at +60 mV) is two to three times smaller than that of rat myocytes, it is, nonetheless, a prominent K^+^ outward current in human atrial and ventricular tissue.[@B9]-[@B11] Small changes in I~to~ during the early phase of AP can profoundly affect the activation of the other plateau currents, such as Ca^2+^ and I~K~, influencing AP duration. Although desflurane appears to inhibit the slowly activating I~K~ and I~Ca,L~ in guinea pig ventricular myocytes,[@B5] the effects of desflurane on I~to~ have not been identified. We explored the effects of desflurane on I~to~, I~KI~, and I~Ca,L~ in order to further elucidate the mechanisms of prolonging APs in rat ventricular myocytes.

MATERIALS AND METHODS
=====================

The animal procedures conformed to a protocol approved by the Yonsei University College of Medicine Animal Research Committee (Seoul, Korea).

Myocyte isolation
-----------------

The rat hearts (Sprague-Dawley, weighing 250-300 g) were quickly excised following enflurane anesthesia and retrogradely perfused using a Langendorff perfusion system for 5 min at 37℃. Perfusion was done at a rate of 7 mL/min with a modified Tyrode solution (143 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl~2~, 0.5 mM MgCl~2~, 5 mM HEPES, and 5.5 mM glucose, pH 7.4). The perfusate was then switched to a nominally Ca^2+^-free Tyrode solution for 5 min, followed by perfusion with the same solution containing collagenase (0.4 mg/mL, Worthington type II, Worthington Biochemical Corporation, Lakewood, NJ, USA) and hyaluronidase (0.4 mg/mL, Sigma type II, Sigma-Aldrich Co., St. Louis, MO, USA). After a 10-12 min enzymatic treatment, a final perfusion was performed for 5 min with Kraftbrühe solution (10 mM taurine, 10 mM oxalic acid, 70 mM glutamic acid, 35 mM KCl, 10 mM H~2~PO~4~, 11 mM glucose, 0.5 mM EGTA, and 10 mM HEPES, pH 7.4). The ventricles were then cut off, minced with scissors, and agitated in a small beaker of Kraftbrühe solution. The resulting slurry was filtered through a 200-µm nylon mesh. The isolated ventricular cells were stored in Kraftbrühe solution for 1 hour at room temperature (21-22℃), then kept at 4℃, and used within a period of 8 hours. Only rod-shaped cells with apparent striations that remained quiescent in the solution containing 2 mM CaCl~2~ were used for the experiments. The whole-cell voltage-clamp studies were performed at room temperature to enhance the viability of the isolated myocytes during recording.

Fifty-seven ventricular cells from 30 rats were used in this study. Single cells were used in most experiments, but replicate experiments in single cells were carried out in part in I~KI~ measurements. In nine cells used for measurement of I~KI~, we replicated measurement of I~KI~ in six cells following measurements of I~to~, because recovery of I~to~ following wash-out was usually complete. We confirmed that the results of I~KI~ between three single cells and six replicate cells were consistent with no alteration of I~KI~ by desflurane.

Electrophysiologic techniques
-----------------------------

Isolated myocytes were allowed to settle to the bottom of a recording chamber and mounted on an inverted microscope, where bathing solutions could be exchanged. The chamber was continuously perfused at a constant rate (2 mL/min). Standard whole-cell voltage-clamp methods were used.[@B12] In order to establish a stable baseline, an interval of 4-6 min was allowed after initiating the whole-cell recording configuration. Voltage-clamp measurements were performed using an Axopatch 200B patch clamp amplifier (Axon Instruments Inc., Foster City, CA, USA). Patch electrodes were prepared from a borosilicate glass model KIMAX-51 (American Scientific, Charlotte, NC, USA) with a two-stage micropipette puller. The pipette tips were heat-polished, using a microforge, giving a typical resistance of 2-3 MΩ when filled with an internal solution. Data acquisition was performed using a pCLAMP system version 6.0 (Axon Instruments Inc., Foster city, CA, USA).

Voltage-clamp protocols
-----------------------

The APs were elicited in current-clamp mode by 5-ms, 800-pA current injections at a frequency of 1 Hz.

To examine the I~to~, the cells were depolarized to -40 mV for 50 ms from a holding potential of -80 mV to inactivate the Na^+^ current, then depolarized to test potentials up to +60 mV in 10-mV increments for 300 ms. To obtain more information about the possible mechanism of the desflurane-induced voltage blockade of K^+^ currents, the voltage dependence of steady-state inactivation was determined using a standard double-pulse protocol. The membrane potential was initially clamped at -80 mV and stepped to different potentials ranging from -100 to 0 mV in 10-mV increments for 500 ms followed by a 200-ms test pulse to +80 mV. The voltage clamp protocol was repeated every 2 s. Steady state inactivation data were fitted to a Boltzmann distribution of the following equation: I/I~max~=I/{1+exp \[(V-V~1/2~)\]/κ}, where I~max~ is the maximal current, V~1/2~ is the membrane potential producing 50% inactivation, and κ is the slope factor.

To determine whether the acceleration of I~to~ inactivation in the presence of desflurane could be associated with time-dependent closure of the open channels, the magnitude of current inhibition at various times after the initiation of the depolarizing pulse was determined at a membrane potential of +60 mV. The outward current in the presence of each desflurane concentration, normalized to the control outward current, was plotted as a function of time after the start of depolarization. Because inactivation increases exponentially during depolarization, the equation \[(I~control~-I~drug~)/I~control~=a~1~×(1-e^-t/τ^)+a~2~\] was used to describe the rate of inhibition of I~to~ at each desflurane concentration where τ is the time constant of inhibition development. (I~control~-I~drug~)/I~control~ equals the amount of inhibition at time t, a~1~ equals the maximum inhibition at a drug concentration, and a~2~ equals the zero intercept. The extrapolation to \"time zero\" shows the proportion of channels inhibited before the start of the pulse, which is an indirect measure of the proportion of channels inhibited in the resting state.[@B13]

The outward currents activated by depolarizing voltage steps in rat ventricular myocytes consist of a rapidly inactivating component, I~to~, and a non-inactivating, sustained component, I~sus~.[@B14],[@B15] The sustained outward current (I~sus~) was recorded with the same voltage protocol after addition of 5 mM 4-aminopyridine in a modified Tyrode solution, which preferentially blocks I~to~. I~sus~ in adult rat ventricular myocytes is responsible for the slower phase of AP repolarization back to the resting membrane potential.[@B16] The I~sus~, comprised of I~K~ and a small time-independent outward current,[@B14] remain in the presence of 4-aminopyridine.

I~KI~ was measured following step depolarizations from -140 to -40 mV from a holding potential of -40 mV in 20 mV increments, using a 200-ms pulse applied at 5-s intervals.

Voltage-dependent I~Ca,L~ was evoked by step depolarization for 500 ms from a holding potential of -40 mV to +0 mV in one step at a frequency of 0.1 Hz.

After baseline measurements, the myocytes were exposed to 6% or 12% desflurane for 2-3 min, and recovery responses were measured after washing for 2-3 min to remove the drug. Applying desflurane for 2 min produced a stable and consistent effect in the pilot experiments.

Solutions and chemicals
-----------------------

Before establishing the whole-cell recording configuration, modified Tyrode solution (140 mM NaCl, 5.4 mM KCl, 1 mM CaCl~2~, 1 mM MgCl~2~, 5 mM HEPES, 10 mM glucose, adjusted to pH 7.4 with 1 N NaOH) was used as an external bathing solution. For K^+^ current measurements, a patch pipette solution (20 mM KCl, 110 mM K-aspartate, 10 mM EGTA, 10 mM HEPES, 1 mM MgCl~2~, 5 mM K~2~ATP, 1 mM CaCl~2~, 10 mM NaCl, adjusted to pH 7.2 with 3 N KOH) was used. To measure I~sus~, 5 mM 4-aminopyridine was added to the modified Tyrode solution and the pH corrected to 7.4 with HCl. In order to eliminate any confounding Ca^2+^ current from the K^+^ current studies, 0.2 mM CdCl~2~ was added to the external solution after establishing the whole-cell voltage-clamp.

The inward Ca^2+^ current was measured using a patch pipette solution (30 mM CsCl, 100 mM aspartic acid, 100 mM CsOH, 10 mM BAPTA, 10 mM HEPES, 10 mM phosphocreatine, 1 mM Na~2~GTP, 5 mM Na~2~ATP, 10 mM glucose, 2 mM MgCl~2~, adjusted to pH 7.2 with 1 M CsOH). Once whole-cell recording was achieved, the bathing solution was exchanged for a solution containing 140 mM NaCl, 5.4 mM CsCl, 2 mM CaCl~2~, 1 mM MgCl~2~, 10 mM HEPES, adjusted to pH 7.4 with 1 M CsOH. Desflurane was purchased from the Baxter Healthcare Corporation (Deerfield, IL, USA). All other chemicals were purchased from Sigma-Aldrich Co.

Before perfusion, the external bathing solution was equilibrated in a reservoir with desflurane, which was supplied by a gas dispersion tube connected to an outlet of the desflurane vaporizer for 15 min. One hundred percent O~2~ (flow rate: 0.2 L/min) was passed through a desflurane vaporizer (Devapor Type M32600, Dräger AG, Lübeck, Germany). The end-tidal concentrations of desflurane were monitored using a calibrated gas analyzer (Capnomac, Datex, Helsinki, Finland). Six and 12% desflurane corresponded to 0.78±0.05 mM (n=3) and 1.23±0.03 mM (n=3) respectively. Given a Tyrode solution/gas partition coefficient of 0.27 at 22℃,[@B17] the aforementioned desflurane concentrations are equivalent to gas phase concentrations of 7.0% and 11.0%, respectively.

Statistical analysis
--------------------

One-way repeated measures of ANOVA followed by the Student-Newman-Keuls test were applied to test for significant differences among the control, drug application, and washout. Unpaired t-tests were used to compare differences in I~to~ currents between 6% and 12% desflurane. All values are expressed as mean±SD. A *p* value of less than 0.05 was considered significant. In the case of results that were not normally distributed, ANOVA of ranks was used, followed by the Student-Newman-Keuls test. In this case, results are expressed as median (IQR). Statistical comparisons were conducted with Sigmastat (SPSS Inc., Chicago, IL, USA) and all figures were prepared using Origin (Microcal Software Inc., Northampton, MA, USA).

RESULTS
=======

Normal action potential
-----------------------

[Fig. 1](#F1){ref-type="fig"} shows the concentration-dependent prolongation of AP in a rat ventricular myocyte. APD~50~ and APD~90~ was prolonged by 42±26% (*p*\<0.05) and 21±13% (*p*\<0.05), respectively, in the presence of 1.23 mM desflurane in 10 cells. AP amplitude and resting membrane potential remained unaltered ([Table 1](#T1){ref-type="table"}). AP duration returned to the baseline following washout.

Transient outward K^+^ current
------------------------------

At +60 mV, 0.78 mM desflurane reduced the control peak currents of I~to~ (3.17±0.86 nA) by 20±8% in 10 cells (*p*\<0.05), and the plateau currents measured at the end of depolarization \[1.12 (0.92-1.35) nA\] by 9% (8.8-9.6%) (*p*\<0.05). Desflurane 1.23 mM reduced the control peak currents of I~to~ (3.27±1.03 nA) by 32±7% in 10 cells (*p*\<0.05) and the plateau currents (1.37±0.32 nA)\] by 13±14% (*p*\<0.05) ([Fig. 2](#F2){ref-type="fig"}). Both peak and plateau currents were completely recovered after wash.

Under control conditions, the voltage required for half-inactivation (V~1/2~) and slope factor (κ) for I~to~ were -29.3±0.6 mV and 7.8±0.5 mV, respectively, in 10 cells. Desflurane 1.23 mM significantly shifted the steady-state inactivation curve in a hyperpolarizing direction (V~1/2~=-34.3±0.9 mV, κ=9.95±0.8) ([Fig. 3](#F3){ref-type="fig"}).

[Fig. 2A](#F2){ref-type="fig"} shows that desflurane accelerates decay of the current during the pulse, so we evaluated the effect of desflurane on I~to~ inactivation kinetics. Individual current records, evoked by a test pulse to +60 mV, were fitted to an exponential function. Unlike the control currents in which the decay could be fitted by a single exponential, inactivation of I~to~ in the presence of desflurane was better described by a double exponential. [Fig. 4A and B](#F4){ref-type="fig"} show the quality of fit of the single and double exponential functions to the inactivation phase of I~to~ under the control and 1.23 mM desflurane conditions. The control ~τ1~ (26±10 ms) was reduced to 9±4 ms by 1.23 mM desflurane in 7 cells (*p*\<0.05). Inactivation kinetics returned to baseline values following washout (24±8 ms) ([Fig. 4C](#F4){ref-type="fig"}).

[Fig. 5](#F5){ref-type="fig"} shows inhibition of I~to~ between the control and in the presence of 0.78 mM and 1.23 mM desflurane during the first 60 ms of depolarization. Inhibition induced by desflurane was an exponential function of time. Both the magnitude of the maximum inhibition and its rate of development appeared to be concentration-dependent. The maximum amount of inhibition by 0.78 mM and 1.23 mM desflurane were 0.58±0.11 and 0.82±0.09 in 8 cells, respectively. The time constants for the increased decline in current were 32±13 ms and 12±7 ms, respectively, for 0.78 mM and 1.23 mM desflurane.

Sustained outward current
-------------------------

Desflurane (1.23 mM) had no effect on I~sus~ ([Fig. 6](#F6){ref-type="fig"}). Before desflurane exposure, the baseline I~sus~ values at the end of the plateau at +60 mV were 1.12±0.24 nA in six cells.

Inward rectifier K^+^ current
-----------------------------

At membrane potential ranging from -140 mV to -40 mV, 1.23 mM desflurane did not alter I~KI~ in nine cells ([Fig. 7](#F7){ref-type="fig"}). I~KI~ was measured at the end of the pulse duration. Prior to desflurane exposure, the baseline values during test potential of -140 mV were -2.52±0.73 nA.

L-type Ca^2+^ current
---------------------

At +10 mV, 1.23 mM desflurane reduced the I~Ca,L~ by 40±6% in 8 cells (*p*\<0.05) ([Fig. 8](#F8){ref-type="fig"}). The effects of desflurane on I~Ca,L~ were completely reversed following washout. The baseline values before exposure to 1.23 mM desflurane were -2.24±0.83 nA.

DISCUSSION
==========

Our results showed that clinically relevant desflurane concentrations prolonged AP duration in isolated rat ventricular myocytes and significantly inhibited I~to~ and I~Ca,L~. Desflurane significantly accelerated current inactivation of I~to~ and shifted the steady-state inactivation curve.

Desflurane prolongs ventricular AP duration in guinea pigs,[@B5] which supports our results in rats. Considering that the QT interval is in accordance with AP duration in the ventricular myocardium, the prolonged AP duration in guinea pig[@B5] and rat ventricular myocytes in our results may support clinical evidence of a prolonged QTc interval in healthy adults[@B1]-[@B3] and children[@B4] during induction of anesthesia with desflurane.

In rat ventricular myocytes, the cardiac voltage-activated K^+^ current consists of I~to~, which is sensitive to 4-aminopyridine, and I~K~, which is sensitive to tetraethylammonium.[@B16] I~K~ is the prominent voltage-activated outward K^+^ current in frog[@B18] and guinea pig ventricular myocytes.[@B19] However, in rat,[@B20] dog,[@B21] rabbit,[@B22] and human myocytes,[@B10] I~to~ is prominent and plays a significant role in the repolarization phase, particularly in the early phase of AP. In several cardiac tissues, two types of I~to~ have been identified; one is voltage- and Ca^2+^-in dependent, and the other is Ca^2+^ -dependent.[@B23],[@B24] In rat ventricular myocytes, only Ca^2+^-independent I~to~ has been identified.[@B25] The Ca^2+^-independent I~to~ carried predominantly by K^+^ ions has been suggested to be a major determinant of cardiac AP duration because of its size and pronounced frequency dependence.[@B24]

Prolonged AP duration caused by inhibition of I~to~ has been demonstrated with tedisamil, an I~to~ and I~K~ blocker in mammalian cardiac cells, in isolated rat ventricular myocytes[@B26] and in rat papillary muscles.[@B27] The reduction of I~to~ by approximately 20% by 0.78 mM desflurane appears to be a fractional reduction of the current. However, considering the large current density of I~to~ in rat ventricular myocytes, 19.9±2.8 pA/pF at +60 mV,[@B9] desflurane would have a greater effect on the AP plateau phase, prolonging AP.

The results of the present study show that desflurane not only decreased the peak I~to~ but also accelerated the current decay during a sustained depolarization. With sustained depolarization, there was an apparent anesthetic-induced acceleration of the current inactivation that followed an exponential time course. This channel inhibition could be due to an acceleration of the inactivation process involving the channel molecular rearrangement to accelerate the closing of the gate, or might represent desflurane binding and blockade of the open channel that follows an exponential time course during continued depolarization. Nevertheless, the extrapolation to time zero shows that desflurane does not significantly inhibit I~to~ before its activation at the onset of depolarization. The hyperpolarizing shift of the inactivation curve indicates that desflurane does depress I~to~ in part by reducing the availability of I~to~ channels.

I~sus~ contributes to the overall repolarization process in rat ventricular myocytes. In the present study, I~sus~ was not affected by desflurane, whereas desflurane 1.23 mM significantly depressed I~K~ in guinea pig ventricular cells, by approximately 40%.[@B5] Although I~K~ suppression by desflurane in guinea pig ventricular myocytes is mainly responsible for AP prolongation,[@B5] I~sus~ is not likely to contribute to prolongation of AP duration by desflurane in rat ventricular myocytes. Presumably, the subtle change in I~sus~ by desflurane may be attributed to relative variations of I~to~ and I~K~ (I~to~/I~K~) among rat ventricular cells,[@B16] significant inhibition of I~K~ by 4-aminopyridine at concentrations above 1 mM,[@B14] and/or species differences.

The I~KI~ is the primary current that maintains stable cardiac resting membrane potential near the K^+^ equilibrium potential. Thus, inhibition of I~KI~ can result in diastolic depolarization, which can increase cardiac excitability[@B28] and lead to dysarrythmias and abnormal automaticity.[@B29] In our results, desflurane did not alter the inward component of I~KI~, similar to the modest effects on inward and outward components of I~KI~ by desflurane in guinea pig ventricular myocytes.[@B5] The lack of change in the resting membrane potential by desflurane in our results may reflect the lack of effect on I~KI~. In the present study at steady state inactivation, approximately 80% of the I~to~ channels appeared to be available for activation at -40 mV. This indicates that the outward component of I~KI~ above -40 mV includes I~to~ so that the outward component of I~KI~ above -40 mV can be influenced by I~to~ in this preparation.

Even with a prolonged AP duration, our whole-cell voltage-clamp studies revealed a reduction of peak I~Ca,L~. Indirect evidence for inhibition of Ca^2+^ entry by desflurane has been proposed in rat isolated myocardial preparations,[@B30] and suppression of I~Ca,L~ by desflurane has been reported in guinea pig ventricular myocytes.[@B5] Inhibition of I~Ca,L~ would shorten AP duration, but reduction of I~to~ appears to have a greater effect, resulting in lengthening of AP duration.

In human ventricular myocytes, although the current density of I~to~ (8.2±0.7 pA/pF at +60 mV) has been reported to be two or three times smaller than that of rat myocytes, it is, nonetheless, a major outward current.[@B9]-[@B11] Small changes in I~to~ during the early phase of AP in human ventricular myocytes can profoundly affect activation of other plateau currents, such as Ca^2+^ and delayed outward K^+^ currents, influencing both AP duration and Ca^2+^ influx. The overall results of this study demonstrate that, at equivalent anesthetic concentrations, the actions of desflurane are almost identical to sevoflurane.[@B31] The similarity in these basic electrophysiological effects is paralleled by the similarity in clinically observed changes.[@B1]-[@B3]

In conclusion, clinically relevant desflurane concentrations appear to prolong AP duration in rat ventricular myocytes by suppressing I~to~. Considering the similar voltage- and time-dependence of I~to~ between human and rat heart cells,[@B9] desflurane suppression of I~to~ may partially account for clinical observations of QTc prolongation in humans.
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![Effect of desflurane (DES) on action potential duration in a rat ventricular myocyte. C, control.](ymj-53-204-g001){#F1}

![Effects of desflurane (DES) on transient outward K^+^ current (I~to~) in rat ventricular myocytes. (A) Recordings of control, 1.23 mM DES, and recovery in rat ventricular myocytes. Closed and open circles indicate the peak current of I~to~ at every potential in the control and 1.23 mM DES. Triangles represent the plateau currents at the end of the test pulses before (closed) and after (open) applying of 1.23 mM DES. Squares represent the peak (closed) and plateau (open) currents after wash. The currents shown are for depolarization from -40 to +60 mV in 10 mV steps. (B) Current-voltage relations of I~to~ in 10 cells. Closed and open circles indicate the peak current of I~to~ at every potential in the control and 1.23 mM DES. Triangles represent the plateau currents at the end of the test pulses before (closed) and after (open) application of 1.23 mM DES. (C) Effects of 0.78 mM and 1.23 mM DES on the amplitude of the peak I~to~ at +60 mV in 10 cells. ^\*^*p*\<0.05 versus control. ^†^*p*\<0.05 versus 0.78 mM DES. Error bars indicate mean±SD.](ymj-53-204-g002){#F2}

![Steady state inactivation curves of transient outward K^+^ currents under control conditions and 1.23 mM desflurane (DES). Closed and open circles indicate control and 1.23 mM DES, respectively. Data are presented as mean±SD for 10 cells and were fitted with the Boltzman function. The half inactivations (V~1/2~) of the control and 1.23 mM DES were -29.3±0.6 mV and -34.3±0.9 mV, respectively.](ymj-53-204-g003){#F3}

![Effect of desflurane (DES) on current inactivation. The inactivation phase of transient outward K^+^ current (I~to~) were best fitted by single and double exponential functions under control conditions (A) and 1.23 mM DES (B), respectively, in a rat ventricular myocyte. Mean values of [T]{.smallcaps}~1~ in 7 cells under control conditions, 1.23 mM DES, and after washout (C). ^\*^*p*\<0.05 versus control and recovery. Error bars indicate mean±SD.](ymj-53-204-g004){#F4}

![Time-dependent inhibition of transient outward K^+^ currents (I~to~) by desflurane. Time course of the development of inhibition by 0.78 mM and 1.23 mM desflurane in each of the 8 cells during a depolarizing pulse to +60 mV from a holding potential of -40 mV. The reduction of I~to~ in the presence of desflurane is expressed as a proportion of the control current at any given time after the start of the depolarizing pulse.](ymj-53-204-g005){#F5}

![The effects of desflurane (DES) on sustained outward currents (I~sus~) in a rat ventricular myocyte. (A) A control recording of transient outward K^+^ currents (I~to~). (B) I~sus~ obtained after application of 5 mM 4-aminopyridine (4-AP), which preferentially blocks I~to~. (C) 1.23 mM DES exposure after application of 5 mM 4-aminopyridine.](ymj-53-204-g006){#F6}

![Effect of desflurane (DES) on the inward rectifier K^+^ current (I~KI~) in rat ventricular myocytes. (A) Closed and open circles indicate control and 1.23 mM DES in a rat ventricular myocyte, respectively, at a membrane potential of -140 mV. The dotted line indicates recovery after wash. (B) Current-voltage relations for I~KI~ before and after applying 1.23 mM DES in 9 cells. Closed and open circles indicate control and 1.23 mM DES, respectively. Error bars indicate mean±SD.](ymj-53-204-g007){#F7}

![Effect of desflurane (DES) on L-type Ca^2+^ current (I~Ca,L~). (A) A representative example of the effect of DES on I~Ca,L~ in a rat ventricular myocyte. The open circles represent the peak of an individual current record. The horizontal bar indicates the period of DES application. (B) An example of individual currents recorded in the presence of 1.23 mM DES. Closed and open circles indicate control and 1.23 mM DES, respectively. The dotted line indicates recovery after wash.](ymj-53-204-g008){#F8}
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Effects of Desflurane (1.23 mM) on Action Potential Characteristics in Isolated Rat Ventricular Myocytes
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RMP, resting membrane potential; AMP, action potential amplitude; APD~50~, action potential duration measured at 50% of repolarization; APD~90~, action potential duration measured at 90% of repolarization.

Values represent mean±SD. n=10 cells.

^\*^*p*\<0.05, different from control and washout values.
